⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 46 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 18, 2026

Jext 300 Mikrogramm Injektionslösung in einem Fertigpen 300 mg (Injektionslösung)

📷 EU Safety Watch placeholder
Jext 300 Mikrogramm Injektionslösung in einem Fertigpen 300 mg (Injektionslösung)
📷 EU Safety Watch placeholder
Parallel export ban in effect; product unavailable since 17 August 2026 with resupply expected 17 October 2026.
⚠️
Shortage ongoing
EPINEPHRIN HYDROGENTARTRAT is currently in short supply in AT.
📈 Timeline
24 days active so far
August 19, 2026 September 11, 2026

What is this? Jext is a pen that gives a quick shot of medicine called epinephrine. It is used in emergencies for severe allergic reactions.

What's happening? The supply of Jext pens is delayed. They are not available right now but are expected back in October.

Does this affect me? If you use Jext pens in Austria, you may not find them at the pharmacy.

What should I do? Ask your pharmacist or doctor for advice on what to do until the pens are back.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
EPINEPHRIN HYDROGENTARTRAT
Agency-published detail

🚫 Parallel export ban active · ATC: C01CA24 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Alk-Abello A/S, Boege Alle 6/8, 2970 Hoersholm, Kingdom of Denmark · Affected packs: 1 Stück Schachtel, Fertigpen [Nicht verfügbar, since 2026-08-17, resupply 2026-10-17]

First published
August 18, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Jext 300 Mikrogramm Injektionslösung in einem Fertigpen 300 mg (Injektionslösung). Parallel export ban in effect; product unavailable since 17 August 2026 with resupply expected 17 October 2026.
▸ When was this alert issued?
This alert was issued on August 18, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.